First New Treatment for Rare Blood Disorder in 30 Years
After nearly three decades, the FDA just approved a breakthrough treatment for essential thrombocythemia, a rare blood disorder affecting thousands. The long-acting therapy showed ten times better results than existing options.















%2Ffile%2Fdailymaverick%2Fwp-content%2Fuploads%2F2024%2F05%2F2024-05-09T023543Z_711097933_RC2PM7AUWUAE_RTRMADP_3_AUSTRALIA-GAS.jpg)

